Andreas M Zeiher Selected Research

Injection Site Reaction

4/2024	Safety Of The Pcsk9 Inhibitor Alirocumab: insights From 47,296 Patient-Years Of Observation.
11/2018	Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas M Zeiher Research Topics

Disease

54	Myocardial Infarction 01/2022 - 01/2002
36	Acute Coronary Syndrome 10/2023 - 08/2002
35	Heart Failure 05/2024 - 09/2004
34	Coronary Artery Disease (Coronary Atherosclerosis) 12/2021 - 01/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 05/2024 - 10/2004
21	Ischemia 01/2018 - 02/2003
19	Infarction (Infarctions) 01/2024 - 12/2002
15	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 12/2002
12	Inflammation (Inflammations) 07/2022 - 01/2004
10	Atherosclerosis 01/2021 - 01/2002
9	Ischemic Stroke 04/2024 - 01/2019
9	Aortic Valve Stenosis (Aortic Stenosis) 07/2022 - 06/2013
8	Diabetes Mellitus 04/2024 - 03/2005
8	Coronary Disease (Coronary Heart Disease) 01/2022 - 03/2015
8	Unstable Angina 01/2022 - 01/2002
8	Hypoxia (Hypoxemia) 11/2020 - 07/2002
6	COVID-19 10/2022 - 11/2020
6	Hypertension (High Blood Pressure) 09/2022 - 07/2004
6	Stroke (Strokes) 01/2022 - 06/2005
6	Disease Progression 07/2021 - 10/2004
6	Chest Pain (Chest Pains) 01/2018 - 03/2003
6	Hypertrophy 11/2011 - 02/2002
6	Necrosis 02/2007 - 04/2003
5	Heart Diseases (Heart Disease) 10/2022 - 07/2004
4	Atherosclerotic Plaque (Atheroma) 01/2021 - 01/2004
4	Infections 01/2021 - 03/2005
4	Dyslipidemias (Dyslipidemia) 12/2019 - 02/2008
4	Neoplasms (Cancer) 01/2018 - 02/2007
4	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2013 - 05/2002
3	Chronic Renal Insufficiency 04/2024 - 10/2018
3	Fibrosis (Cirrhosis) 01/2023 - 04/2012
3	Hemorrhage 01/2022 - 01/2019
3	Atrial Fibrillation 01/2022 - 07/2015
3	Cardiomyopathies (Cardiomyopathy) 12/2021 - 08/2007
3	Wounds and Injuries (Trauma) 09/2012 - 01/2002
3	Vascular Remodeling 02/2012 - 09/2003
3	Ventricular Remodeling 02/2012 - 06/2005
3	Pathologic Constriction (Stenosis) 11/2005 - 10/2003
2	Injection Site Reaction 04/2024 - 11/2018
2	Cardiomegaly (Heart Hypertrophy) 11/2023 - 02/2002
2	Thrombosis (Thrombus) 10/2023 - 08/2002
2	Frailty 01/2022 - 12/2021
2	Cicatrix (Scar) 01/2021 - 01/2019
2	Virus Diseases (Viral Diseases) 01/2021 - 12/2020

Drug/Important Bio-Agent (IBA)

23	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2022 - 01/2002
21	alirocumabIBA 04/2024 - 11/2018
16	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2004
13	C-Reactive ProteinIBA 05/2024 - 04/2003
13	omega-Chloroacetophenone (Mace)IBA 09/2022 - 10/2004
13	TroponinIBA 07/2021 - 12/2004
13	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2010
10	erucylphosphocholineIBA 11/2010 - 08/2003
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
8	LDL CholesterolIBA 09/2022 - 07/2004
8	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 04/2007
7	Troponin T (Troponin T1)IBA 05/2024 - 01/2004
7	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 04/2007
7	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2010
7	CytokinesIBA 10/2020 - 04/2003
6	Troponin IIBA 05/2024 - 07/2015
6	Proprotein Convertase 9IBA 01/2022 - 11/2018
6	oxidized low density lipoproteinIBA 12/2020 - 01/2019
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 02/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015 - 08/2002
6	CD40 Ligand (CD40L)IBA 01/2006 - 08/2002
5	Lipoproteins (Lipoprotein)IBA 09/2022 - 01/2019
4	Glycoproteins (Glycoprotein)IBA 09/2019 - 02/2003
4	Trinitrotoluene (TNT)IBA 06/2017 - 01/2004
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2012 - 10/2004
4	Interleukin-10 (Interleukin 10)IBA 07/2008 - 04/2003
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2006 - 01/2004
4	Abciximab (ReoPro)FDA Link 01/2006 - 02/2003
3	Lipoprotein(a)IBA 10/2023 - 01/2020
3	ApolipoproteinsIBA 01/2022 - 11/2018
3	CreatinineIBA 12/2021 - 09/2004
3	Cystatin CIBA 12/2021 - 04/2009
3	Oxygen (Dioxygen)IBA 12/2020 - 01/2004
3	Therapeutic UsesIBA 12/2020 - 02/2003
3	Long Noncoding RNAIBA 11/2020 - 08/2017
3	InterleukinsIBA 10/2020 - 07/2004
3	CollagenIBA 09/2019 - 07/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 09/2008
3	N 30IBA 10/2011 - 10/2004
3	salicylhydroxamic acid (SHAM)IBA 06/2005 - 04/2003
3	Vasodilator Agents (Vasodilators)IBA 10/2004 - 01/2004
2	DNA Methyltransferase 3AIBA 01/2024 - 01/2021
2	AnticoagulantsIBA 01/2022 - 09/2012
2	RevaceptIBA 01/2021 - 09/2019
2	Sirtuin 1IBA 01/2021 - 10/2007
2	EnzymesIBA 01/2021 - 01/2004

Therapy/Procedure

49	Therapeutics 01/2022 - 01/2002
21	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018 - 05/2003
15	Transplantation 10/2011 - 12/2002
10	Transcatheter Aortic Valve Replacement 01/2023 - 06/2013
6	Percutaneous Coronary Intervention 01/2021 - 11/2005
6	Stents 12/2006 - 01/2002
5	Patient Readmission 01/2019 - 12/2006
4	Intravenous Infusions 09/2019 - 11/2003
3	Heart Transplantation (Grafting, Heart) 03/2012 - 08/2009
2	Prostheses and Implants (Prosthesis) 05/2021 - 01/2019